Furthermore, through corresponding functional assays, indicated that SOX9 was an oncogene, overexpression of SOX9 altered the inhibition of cancer cell promotion mediated by lncRNA HCG18 knockdown through PI3K/AKT pathway. This evidence concerns the gene HCG18 and cancer.